Abstract
Although transition to sirolimus (SRL) as primary immunosuppression has been associated with an improvement in glomerular filtration rate (GFR), long term follow up (FU) has not been reported. The aim of this study was to evaluate GFR in SRL treated patients and to compare with patients remained on CNIs during 5 years FU.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
